News

DUBLIN and BARCELONA, Spain – Aug. 29, 2022 –Medtronic plc announced that its investigational EV ICD™ System – a first-of-its-kind defibrillator with the lead placed under the breastbone, outside of the heart and veins – achieved a...

Mount Sinai researchers led the international ENVISAGE-TAVI trial across 173 centers in 14 countries to compare the safety and efficacy of different therapies in AF/TAVR patients who need oral anticoagulation.

TIME trial presented in a Hot Line Session at ESC Congress 2022

Modern design advances patient care by combining hemostasis with innovative cooling capability.

Tim Laird joins as Vice President of Sales. Kathryn Wilamowski joins as Senior Manager, Quality Systems.

The U.S. FDA approved a clinical trial to evaluate the safety and efficacy of the Thermedical® SERF Ablation System with the Durablate® Catheter in people with ventricular tachycardia (VT) resistant to conventional treatment. VT is a leading...

A first-in-human multicenter trial involving Mayo Clinic used a new ablation technique for patients with ventricular tachycardia, an abnormally rapid heart rhythm that is a leading cause of sudden cardiac death worldwide.

Funding Will Accelerate Commercialization of the ECGenius™ System and Expand Development of Analytic Modules.

Company sees increase in medical centers entering into 60-day evaluation agreements. Existing customers seeing positive results from PURE EP™ System expected to increase number of units purchased.